Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Digital game to help manage heart failure

Official title: Sensor-controlled Digital Game for Heart Failure Selfmanagement Behavior Adherence: A Randomized Controlled Trial

Run by University of Texas at Austin · NCT05056129 · Data updated 2026-11-12

This study is testing a fun digital game to see if it can help adults with heart failure manage their health better by encouraging them to monitor their weight and stay active.

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Texas at Austin
Academic / other
Locations1 site (Austin, Texas)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedDecember 30, 2025
Study endsJanuary 31, 2026
Registry record updatedJanuary 16, 2026
Trial IDNCT05056129 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 45 and older with a New York Heart Association classification of I to III who have experienced heart failure hospitalization in the past year.

Probably not a fit

Patients with severe visual or tactile impairments, end-stage illnesses, or those who have undergone heart transplantation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a sensor-controlled digital game designed to motivate self-management behaviors in adults with heart failure. Participants will be randomly assigned to either receive the digital game app along with weight monitoring and physical activity sensors or just the sensors alone. The game provides real-time feedback and rewards based on participants' weight and activity levels, aiming to encourage healthier behaviors. The primary goal is to assess the effectiveness of this intervention in improving self-management practices among heart failure patients.

Why it matters

Potential benefit: If successful, this approach could enhance self-management and improve health outcomes for patients with heart failure.

How similar studies have gone: While the use of digital games for health management is a growing field, this specific approach using a sensor-controlled game for heart failure self-management is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 45 years or older
* New York Heart Association (NYHA) heart failure classification of I to III that permits minimal physical activity without discomfort
* have experienced HF hospitalization in the past 12 months
* be fluent in English
* Pass a mini-cognitive screen
* Score of less than 2 (able to independently walk without using a cane or walker) on the Outcome and Assessment Information Set item for ambulation/locomotion

Exclusion Criteria:

* severe visual (e.g., legally blind) or tactile (e.g., severe arthritis) impairments that adversely prevent the use of a smartphone or sensor devices;
* a history of renal failure, which adversely affects HF prognosis
* a diagnosis of an end-stage or terminal illness (e.g., cancer)
* undergone heart transplantation, or implantation of a durable mechanical circulatory support device (e.g., left ventricular assist device) due to unique self-management needs.

Where it's running

  • The University of Texas Austin
    Austin, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.